Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

ABSTRACT: Risk-based treatment approaches for neuroblastoma have been ongoing for decades. However, the criteria used to define risk in various institutional and cooperative groups were disparate, limiting the ability to compare clinical trial results. To mitigate this problem and enhance collaborative research, homogenous pretreatment patient cohorts have been defined by the International Neuroblastoma Risk Group classification system. During the past 30 years, increasingly intensive, multimodality approaches have been developed to treat patients who are classified as high risk, whereas patients with low- or intermediate-risk neuroblastoma have received reduced therapy. This treatment approach has resulted in improved outcome, although survival for high-risk patients remains poor, emphasizing the n

SUBMITTER: Pinto NR 

PROVIDER: S-EPMC4567703 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature